Pixium Vision announced on Monday that the Paris Commercial Court will rule on December 18 on the only takeover offer received by its receivers.Coinciding with this decision, the courts will also have...
Pixium Vision announces the 48-Month Trial Results in Severe Atrophic AMD Study confirms subretinal prothesis feasible and well-tolerated with no reduction of natural peripheral vision, confirming...
Pixium Vision announces the conversion of the safeguard proceedings into receivership Paris, France, November 13, 2023 – 8:00 pm – Pixium Vision SA , a bioelectronics company developing...
Pixium Vision SA , a bioelectronics company developing innovative vision systems to enable patients who have lost their sight to live more independent lives, announces that a tender process for the...
Visiongain has published a new report entitled Bionic Devices Market Report 2023-2033: Forecasts by Fixation (Implantable Bionics, External Bionics), by...
Results of the Annual General Shareholder Meeting as of June 13, 2023 Paris, France, June 15, 2023 – 07:00 CET – The Annual General Shareholder Meeting of Pixium... | June 15, 2023
Pixium Vision announces receipt of € 1.8 million from the French Government as Research Tax Credit €1.8 million research tax credit received on June 7, 2023, to extend runway... | June 8, 2023
Annual Meeting of Shareholders June 13, 2023 Availability of preparatory documents Paris, France, May 24, 2023 – 19:00 CET– Pixium Vision SA , a bioelectronics company that develops... | May 24, 2023
Manufacturers in the bionic eye market are earning more due to rapid innovations & developments in bionic eye technologies. Acquire Fact.MR’s market report...
Pixium Vision welcomes judgment by Paris Commercial Court against Second Sight Medical Products Court finds Second Sight Medical Products breached 2021 contractual obligations to Pixium... | December 28, 2022